Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Denosumab | Case report

Denosumab/Prednisolone

Osteoporosis and severe hypocalcaemia

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Aktas M, et al. A Rare Reason for Severe Hypocalcemia Following Kidney Transplant: Denosumab Treatment. Experimental and Clinical Transplantation 22 (Suppl. 1) : 342-344, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.6002/ect.MESOT2023.P10 Aktas M, et al. A Rare Reason for Severe Hypocalcemia Following Kidney Transplant: Denosumab Treatment. Experimental and Clinical Transplantation 22 (Suppl. 1) : 342-344, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.6002/ect.MESOT2023.P10
Metadata
Title
Denosumab/Prednisolone
Osteoporosis and severe hypocalcaemia
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55538-y

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Glucose

Case report

Ketamine

Case report

Multiple drugs

Case report

Antineoplastics